News Releases

Select Access™ to Co-Promote Anti-Viral Oral Medication

Seasonal agreement is second contract with expanded coverage

Saddle River, NJ— (September, 2006) PDI, Inc. (NASDAQ: PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, has announced that its Select Access™ unit has been awarded a seasonal contract to promote an anti-viral oral medication from September 2006 – April 2007. This is the second year a contract has been awarded to Select Access to detail this medication, and represents an expansion to 250,000 calls to primary care physicians and pediatricians, 85% of which are in primary position.  Select Access will have exclusive call coverage of pediatricians and their calls to primary care physicians will be heavily weighted to high subscribers.

Select Access has a unique selling model where multiple, non-competitive clients can access a fully operational sales force in high prescribing zip codes with a high percentage of first detail position calls. Since the sales team, and its cost, are leveraged across multiple clients, Select Access™ is effective for over-the-counter; and Rx established, seasonal and specialty products.

 “We are very pleased to be able to provide this much needed seasonal pulse to our client,” said Nancy Connelly, Senior Vice President and General Manager of Select Access. “The fact that they have come back to us again this year, and significantly increased our contract responsibilities is certainly proof that our model is effective in maximizing brand profitability.”

About Select Access

Select Access, a targeted sales solution for a diverse group of pharmaceutical products, leverages an existing infrastructure to maximize brand profitability. Rapid deployment and national coverage by approximately 350 experienced sales representatives in high prescribing territories increases speed to impact. Select Access™ is the only alternative sales force model that gives clients complete target audience control and flexibility and where the majority of sales calls are single detail.

Select Access' unmatched value is perfectly aligned to increase incremental revenue for seasonal,  established,  and OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence.

About PDI

PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry offering a comprehensive set of outsourced sales and marketing solutions for established and emerging pharmaceutical companies.  PDI is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing, and commercialization expertise; and a philosophy of performance.
 
Headquartered in Saddle River, NJ, PDI’s sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients, and Select Access™, our targeted sales solution that leverages an existing infrastructure.  PDI also offers marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL.  In addition, PDI is a high quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM ®) in Dresher, PA.  The company’s experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.  
 
PDI’s commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients.  Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry.  Recognized as an industry pioneer, PDI remains committed to continuous innovation and to maintaining the industry’s highest quality employees.
 
For more information, visit the Company’s website at www.pdi-inc.com.
For more information about Select Access, visit www.select-access.com.

For more information contact:       
Nancy Connelly
Senior Vice President and General Manager-Select Access
PDI, Inc.
201.574.8683

Copyright © Select Access, a division of PDI, Inc. • Information Privacy Policy

About Select Access | Markets Served | Press & Media | Target Coverage Analysis | Contact Us | PDI, Inc.